Function of atypical mammalian oocyte/zygote nucleoli and its implications for reproductive biology and medicine
Jazyk angličtina Země Španělsko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
31058290
DOI
10.1387/ijdb.180329jf
PII: 180329jf
Knihovny.cz E-zdroje
- MeSH
- buněčné jadérko fyziologie MeSH
- časové faktory MeSH
- embryo savčí MeSH
- embryonální vývoj MeSH
- fertilizace MeSH
- heterochromatin fyziologie MeSH
- lidé MeSH
- maternální dědičnost MeSH
- myši MeSH
- nukleoplasminy genetika MeSH
- oocyty fyziologie ultrastruktura MeSH
- zvířata MeSH
- zygota fyziologie MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- heterochromatin MeSH
- Npm2 protein, mouse MeSH Prohlížeč
- nukleoplasminy MeSH
Mammalian oocytes/zygotes contain atypical nucleoli that are composed exclusively of a dense fibrillar material. It has been commonly accepted that these nucleoli serve as a repository of components that are used later on, as the embryo develops, for the construction of typical tripartite nucleoli. Indeed, when nucleoli were removed from immature oocytes (enucleolation) and these oocytes were then matured, fertilized or parthenogenetically activated, development of the produced embryos ceased after one or two cleavages with no detectable nucleoli in nuclei. This indicated that zygotic nucleoli originate exclusively from oocytes, i.e. are maternally inherited. Recently published results, however, do not support this developmental biology dogma and demonstrate that maternal nucleoli in one-cell stage embryos are necessary only during a very short time period after fertilization when they serve as a major heterochromatin organizing structures. Nevertheless, it still remains to be determined, which other functions/roles the atypical oocyte/zygote nucleoli eventually have.
Citace poskytuje Crossref.org
Improving the Quality of Oocytes with the Help of Nucleolotransfer Therapy